Triazolotriazines and pyrazolotriazines and methods of making and using the same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 23, 2007
Grant Date -
Dec 7, 2006
app pub date -
Apr 9, 2004
filing date -
Apr 9, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention is based on the discovery that compounds of formula (I) possess unexpectedly high affinity for the A.sub.2a adenosine receptor, and can be useful as antagonists thereof for preventing and/or treating numerous diseases, including Parkinson's disease. In one embodiment, the invention features a compound of formula I: (I) ##STR00001##
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully